Search Results

This forum will bring together senior executives with thought leaders from MIT to explore the best methods for creating and organizing corporate innovation and venturing groups. We will also discuss how the MIT Industrial Liaison Program (ILP) helps firms engage with the world-leading thinkers at MIT who tackle humanity's most vexing challenges and the entrepreneurs who turn MIT innovations into working solutions.

The chemical industry is increasingly leveraging artificial Intelligence in their quest for new synthetic routes and chemical structures used in a wide variety of applications including: building materials, packaging, agrochemicals, pharmaceuticals, and consumer products.  While past efforts focused on optimizing time and cost of producing materials, growing environmental concerns, and new legislation lead manufacturers to address the environmental impact and sustainability of their products. In this webinar we present research on, and application of, computer-assisted technologies to assist researchers and corporate R&D scientists and engineers in identifying and leveraging environmentally friendly chemistry and materials.

The 2024 MIT Startup Ecosystem Conference brings MIT innovation & entrepreneurship resources together to showcase MIT’s rich startup ecosystem. Along with executives from industry-leading corporations and founders, they will engage in lively discussions about breakthrough technologies, technology transfer, funding science-based startups, and startup & corporate engagement, among other topics.

The conference, organized by the MIT Startup Exchange, showcases fourteen startups affiliated with MIT startup resources across campus. They will present and exhibit their game-changing companies throughout the day. Attendees will have the chance to meet the entrepreneurs to learn more about their impactful products and technology.

The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.